Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA clears first neonatal magnetic resonance imaging device

      FDA clears first neonatal magnetic resonance imaging device

      Ruby Khatun Khatun25 July 2017 9:35 AM IST
      The U.S. Food and Drug Administration (FDA) cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging...
      GSK receives FDA approval for Benlysta to treat systemic lupus erythematosus

      GSK receives FDA approval for Benlysta to treat systemic lupus erythematosus

      Ruby Khatun Khatun25 July 2017 9:30 AM IST
      London: GSK receives FDA approval for a new self-injectable formulation of Benlysta (belimumab) for systemic lupus erythematosusGSK announced that the...
      Positive disruptions in the pharma world

      Positive disruptions in the pharma world

      Ruby Khatun Khatun25 July 2017 9:22 AM IST
      Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI) held its fifth annual HR summit in the city. The participants were drawn together...
      Strides Shasun gets USFDA nod for anti-allergy capsules

      Strides Shasun gets USFDA nod for anti-allergy capsules

      Ruby Khatun Khatun25 July 2017 9:20 AM IST
      New Delhi: Strides Shasun on Monday said it has received approval from the US Food and Drug Administration for cetirizine hydrochloride capsules, used...
      Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

      Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

      Ruby Khatun Khatun25 July 2017 9:15 AM IST
      CORNING, N.Y.: Merck, Pfizer and Corning Incorporated announced collaborations that have enabled the modernization of pharmaceutical packaging with...
      Demand notices of Rs 74.65 crore issued to pharma firms: Govt

      Demand notices of Rs 74.65 crore issued to pharma firms: Govt

      Ruby Khatun Khatun24 July 2017 2:12 PM IST
      New Delhi: The government said demand notices of Rs 74.65 crore have been issued to pharmaceutical companies which have launched drugs without prior...
      Janssen gets EU regulatory panels nod for Symtuza to treat HIV

      Janssen gets EU regulatory panel's nod for Symtuza to treat HIV

      Ruby Khatun Khatun24 July 2017 9:30 AM IST
      Beerse, Belgium: Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the...
      Suven Life Sciences secures neuro drug patent from Australia

      Suven Life Sciences secures neuro drug patent from Australia

      Ruby Khatun Khatun24 July 2017 9:30 AM IST
      New Delhi: Suven Life Sciences has been granted a patent from Australia for a drug used in the treatment of disorders associated with...
      USFDA observations beneficial in long run: Dr Reddy

      USFDA observations beneficial in long run: Dr Reddy's

      Ruby Khatun Khatun24 July 2017 9:25 AM IST
      Mumbai: US health regulator's observations are "unmistakably" beneficial in the long run and have helped the company accelerate the pace of quality...
      Headway on AIDS threatened by funding slowdown

      Headway on AIDS threatened by funding slowdown

      Ruby Khatun Khatun24 July 2017 9:15 AM IST
      Paris: Progress in beating back the AIDS epidemic risks being eroded by a funding shortfall set to grow under Donald Trump's proposed cuts to global...
      Vikram Hospital appoints Dr Somesh Mittal as new CEO

      Vikram Hospital appoints Dr Somesh Mittal as new CEO

      Ruby Khatun Khatun24 July 2017 9:00 AM IST
      Bengaluru: Dr Somesh Mittal has been appointed as the CEO of Vikram Hospital, a leading multi-specialty health facility here.The appointment is with...
      Sanofi India Q2 net dips 14 per cent at Rs 73 crore

      Sanofi India Q2 net dips 14 per cent at Rs 73 crore

      Ruby Khatun Khatun23 July 2017 9:53 AM IST
      New Delhi: Drug firm Sanofi India reported a 14.40 per cent dip in its net profit to Rs 73.7 crore for the second quarter ended June.The company had...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok